Vivos Therapeutics, Inc.
Assets & Liabilities
| Period | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| Mar 2022 | $8.5M | $29.6M | $17.8M |
| Jun 2022 | $9.5M | $24.4M | $12.7M |
| Sep 2022 | $8.5M | $18.4M | $6.7M |
| Dec 2022 | $8.9M | $13.7M | $3.5M |
| Mar 2023 | $10.1M | $17.1M | $7.0M |
| Jun 2023 | $11.6M | $13.7M | $3.9M |
| Sep 2023 | $10.3M | $10.3M | $988.0K |
| Dec 2023 | $10.3M | $10.7M | $1.6M |
| Mar 2024 | $11.2M | $11.8M | $2.6M |
| Jun 2024 | $9.5M | $15.8M | $6.9M |
| Sep 2024 | $7.7M | $15.3M | $6.3M |
| Dec 2024 | $7.3M | $15.3M | $6.3M |
| Mar 2025 | $6.9M | $11.3M | $2.3M |
| Jun 2025 | $21.5M | $26.0M | $4.4M |
| Sep 2025 | $23.1M | $25.6M | $3.1M |
| Dec 2025 | $26.7M | $25.2M | $2.0M |
| Mar 2026 | $26.3M | $25.0M | $2.1M |
| Jun 2026 | $28.1M | $24.1M | $1.8M |